saascode
healthcare & clinical·run 003 · Apr 2026

Clairvoy

A specialty-focused ambient documentation workspace that records with consent, links transcript segments to note and coding candidates and requires clinician correction and signature before any chart or billing action.

Genesis score6.17/10
Make Clairvoy real.0/500
500 more votes and Clairvoy is authorized for build.
0%500 to authorize
Backing is the vote. When an idea crosses 500, we pull it into the build pipeline and ship it for real — the votes decide what gets built next, not an editor.
The opportunity
5Confirmed direct SMB competitors
0Verified clinical write interfaces
The case

Solo and small-group clinicians spend substantial time documenting visits and preparing referrals, patient summaries and billing support. Clairvoy records an encounter under an approved consent workflow, separates speakers and produces source-linked draft sections for a defined specialty. The supplied research confirms a crowded ambient documentation market with several low-entry competitors, so price and generic transcription are not differentiation. The narrower wedge is specialty templates, visible provenance and safe operation for small practices. Audio is incomplete and fallible: speakers overlap, medical terms are misheard and clinically relevant examination or reasoning may not be spoken. Generated notes, codes, referral letters and patient summaries are candidates only. The clinician must correct, complete and sign the exact record; a coder or billing owner dispositions codes separately. Recording consent, patient match, transcript, draft statement, clinician correction, signature, chart acknowledgement, coding disposition, billing command, payer result and health outcome remain separate. The product can reduce drafting burden. It cannot replace a scribe or clinician, guarantee coding or documentation accuracy or infer care from audio alone.

Who pays — and why

A solo or small-group specialty practice with consent procedures, a named clinical owner and measurable after-visit documentation burden.

Market signalValidate by clinician seats, encounter minutes, specialty templates, correction time, retained audio policy and chart destinationsAmbient documentation subscriptions, human scribe services and clinical integration are observed market references, not fixed product pricing
What it unlocks
A specialty documentation contract defining supported encounter type, required note elements, prohibited inference, consent, audio retention, patient identity, clinician role and human fallback.
A provenance model separating audio segment, speaker candidate, transcript, note statement, missing required field, clinician correction, signature, coding candidate and patient-summary approval.
A chart and billing chain from signed note through exact destination command, acknowledgement, readback, separate coding disposition, billing authorization, payer result and amendment.
How Genesis scored it
6.17across seven criteria
tension 7temporal 5blindspot 5buyer 7leverage 7convergence 10why-not 5
10
Convergence

Seven cross-references and nine inbound connections support exceptional convergence.

7
Productive tension

Clinicians want less documentation burden, while medical records and codes require complete context, authorship and correction.

5
Why nobody did it

Specialty templates and lower inference cost make the wedge feasible, but many entrants already exist.

Why it scored well

Very high convergence, a concrete small-practice buyer and strong market validation support specialty-focused ambient documentation.

What's holding it back

The SMB market is crowded, no new temporal trigger or structural incumbent barrier is proven, clinical interfaces are unverified and safety and support are demanding.

Signals detected3 sources crossed
SignalCompetitor research

SignalCompetitor research

SignalMarket research

Direction briefclairvoy-specialty-visit-drafts.md
clairvoy-specialty-visit-drafts.md
Want this pointed at your vertical?Point Genesis at your own market and constraints — it invents adjacent, fork-ready ideas, private to you before they hit the public feed.

Discussion

?

No comments yet — be the first to weigh in.